There is growing interest in drug therapies that can support weight loss and thereby reduce the prevalence of obesity and obesity-related complications
GLP-1 Receptor Activity, Appetite, and Satiety GLP-1 receptor activation can increase glucose-dependent insulin release, reduce glucagon secretion, slow gastric emptying, and influence central appetite pathways [11]
However, this may be a viable strategy for GLP-1 RA use in weight management. Jay Horowitz, APRN, CRNA, states, It is imperative to stay on top of new technologies and medication to ensure patient safety and provide optimal care. He has published articles in Outpatient Surgery Magazine sharing his experience as an anesthesia clinical leader working in two fast-paced, progressive, single-specialty (Ophthalmology) ASCs providing local with sedation anesthesia
[Abstract]2026 Jul;33(5):e70070
Lester Packer Handbook of Antioxidants , pp
Whats in the Pack